CoChat

The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.

The selective serotonin reuptake inhibitor, escitalopram, enhances inhibition of prepotent responding and spatial reversal learning

Open access
Brown, Holden D, Amodeo, Dionisio A, Sweeney, John A, Ragozzino, Michael E · 2012 · Journal of Psychopharmacology

Abstract

Previous findings indicate treatment with a selective serotonin reuptake inhibitor (SSRI) facilitates behavioral flexibility when conditions require inhibition of a learned response pattern. The present experiment investigated whether acute treatment with the SSRI, escitalopram, affects behavioral flexibility when conditions require inhibition of a naturally biased response pattern (elevated conflict test) and/or reversal of a learned response pattern (spatial reversal learning). An additional experiment was carried out to determine whether escitalopram, at doses that affected behavioral flexibility, also reduced anxiety as tested in the elevated plus-maze. In each experiment, Long-Evans rats received an intraperitoneal injection of either saline or escitalopram (0.03, 0.3 or 1.0 mg/kg) 30 min prior to behavioral testing. Escitalopram, at all doses tested, enhanced acquisition in the elevated conflict test, but did not affect performance in the elevated plus-maze. Escitalopram (0.3 and 1.0 mg/kg) did not alter acquisition of the spatial discrimination, but facilitated reversal learning. In the elevated conflict and spatial reversal learning test, escitalopram enhanced the ability to maintain the relevant strategy after being initially selected. The present findings suggest that enhancing serotonin transmission with an SSRI facilitates inhibitory processes when conditions require a shift away from either a naturally biased response pattern or a learned choice pattern.

Overview

Integrity signals

Registry

Crossref · 10.1177/0269881111430749

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 82 references

Research works printed but not linked: 3

  1. Ceglia I, 2004, Br J Psychiatry, 142, 469
  2. Graeff FG, 1993, Braz J Med Biol Res, 26, 67
  3. 10.1037/0735-7044.116.1.105 · doi:10.1037/0735-7044.116.1.105 · Paper page

Cited by

See all 56

Metadata

Authors
Brown, H. D., Amodeo, D. A., Sweeney, J. A., & Ragozzino, M. E.
Affiliations
University of Illinois Chicago (US)
Venue
Journal of Psychopharmacology
Published
2012-01-04
Volume
26
Issue
11
Pages
1443-1455
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2045287840
Cited by
56
References
82
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 8 · 2022: 1 · 2021: 6 · 2020: 3 · 2019: 6 · 2018: 6 · 2017: 3 · 2016: 5 · 2015: 5 · 2014: 3 · 2013: 3
FWCI
1.45
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • Pfizer Pharmaceuticals
  • Janssen Pharmaceuticals
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD055751)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
escitalopram, selective serotonin reuptake inhibitors, behavioral flexibility, response inhibition, spatial reversal learning, anxiety, serotonin transmission, rats
MeSH terms
Animals, Anxiety, Behavior, Animal, Disease Models, Animal, Dose-Response Relationship, Drug, Injections, Intraperitoneal, Male, Reversal Learning, Serotonin, Citalopram, Selective Serotonin Reuptake Inhibitors, Maze Learning, Rats, Long-Evans, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The selective serotonin reuptake inhibitor, escitalopram, enhances inhibition of prepotent responding and spatial reversal learning. https://app.cochat.ai/papers/10.1177/0269881111430749
The paper
Brown, H. D., Amodeo, D. A., Sweeney, J. A., & Ragozzino, M. E. (2012). The selective serotonin reuptake inhibitor, escitalopram, enhances inhibition of prepotent responding and spatial reversal learning. Journal of Psychopharmacology. https://doi.org/10.1177/0269881111430749

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.